Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
about
Brain tumorsMiRNA expression patterns predict survival in glioblastoma[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvRelapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?Amino acid PET and MR perfusion imaging in brain tumours.Expression of VEGF and MMP-9 and MRI imaging changes in cerebral glioma.Precision radiotherapy for brain tumors: A 10-year bibliometric analysis.Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experienceRe-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.Relationship between Glioblastoma Dose Volume Parameters Measured by Dual Time Point Fluoroethylthyrosine-PET and Clinical Outcomes.Functional image-guided dose escalation in gliomas using of state-of-the-art photon vs. proton therapy.IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection.
P2860
Q24605136-ADAE81D2-4175-453E-9916-F4BDCD25E9E6Q24629525-19BA0A6E-9E4B-442B-AED2-EFE842F84958Q30442436-F598D46C-7ED9-4C42-92B2-FA5BEE5D62C3Q35679377-E686A03A-B4D1-4F0C-9F34-BAA99EEDA345Q36048800-19E52EB4-8D14-48B9-BC0F-029A69D1D6FEQ37037922-5019F8A4-E45C-4341-9C6C-569EB6323E2BQ38051641-FA96C4C4-0DAE-47FC-BCE9-E5E96E06DCA6Q38403271-9438FB2B-110B-47EC-9947-FB053C99DE7EQ38691946-FB3B6403-4BE1-4970-93A5-130D265CFC33Q39577067-824ADB47-8646-4EA5-B3C8-FF3685350E0BQ41521476-CBF5A528-8F86-491F-8526-192F42D3993BQ42289827-296150CE-AA71-48AE-8C1C-C8F8FF049B87Q48341481-0808A64C-F491-4E1C-8D54-9CBB4A507D05Q48409107-C21E3C4F-F174-4E1C-9418-84EF987B80F5Q48480217-1AD7208A-458B-4813-A651-8E7DF1F40923Q48849722-BAA5124E-7919-46C4-AFB2-2938A10B3DC1Q49770817-1A2E6FAA-8600-426F-B06C-A0860F9F07D6Q52096609-52720D53-136C-4234-99F1-E9835E50758FQ55461687-D6C1C6A6-0D48-4AFE-9F60-0DF5A12B6585
P2860
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@en
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@nl
type
label
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@en
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@nl
prefLabel
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@en
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@nl
P2093
P2860
P356
P1433
P1476
Integrated-boost IMRT or 3-D-C ...... orme--a dosimetric comparison.
@en
P2093
Cengiz Demirel
Charbel Attieh
Gabriele Stoffels
Hans J Kaiser
Karl J Langen
Marc D Piroth
Michael J Eble
Michael Pinkawa
Richard Holy
P2860
P2888
P356
10.1186/1748-717X-4-57
P577
2009-11-23T00:00:00Z
P5875
P6179
1033088355